ACUMED MEDICAL LTD.

What ACUMED MEDICAL LTD. does

ACUMED MEDICAL LTD. is a privately held medical device company, incorporated in the United Kingdom and operating primarily as Dolphin Neurostim / MPS Therapy, that has been in business since 1990 and employs 5 people. The company designs, manufactures, and sells the Dolphin Neurostim, a microcurrent point stimulation device that applies brief, concentrated DC micro-impulses to targeted neurological points to reduce sympathetic nervous system stress, relax muscles, and relieve soft-tissue pain. The device is FDA-approved and Health Canada-approved as a Microcurrent Therapy Device, and is sold in two configurations: a Professional kit for licensed practitioners (physicians, physical therapists, chiropractors, occupational therapists, massage therapists, osteopaths, acupuncturists) and a Patient/OTC kit for home use.

The company operates a vertically integrated business model combining hardware sales with a structured education platform. Revenue is generated through direct-to-consumer e-commerce (dolphinmps.com), a third-party affiliate program, and CEU-accredited training courses delivered online and via live hands-on sessions (mpscourses.com). Beyond general pain management, the company has developed specialized protocols for Vagus Nerve Stimulation, Scar Release Therapy, and Concussion/Brain Therapy, the latter supported by a dedicated microsite. Marketing and lead generation rely on content marketing, a practitioner finder directory (mpstherapist.com), customer testimonials, and YouTube video content. The company claims its technology is in use across more than 60,000 hospitals and pain clinics worldwide, and maintains a 4.8-star Google rating across 159 reviews. There is no disclosed parent company, no public funding, no M&A activity, and no management team information in the available source data.

Name

ACUMED MEDICAL LTD.

Legal name

Acumed Medical, Ltd.

Website

https://acumedmedical.ca

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

1–10 employees

Short description

ACUMED MEDICAL LTD. (Dolphin Neurostim / MPS Therapy) designs, manufactures, and sells an FDA-approved DC microcurrent point stimulation device for pain management, scar release, vagus nerve therapy, and concussion recovery, serving licensed healthcare practitioners and individual consumers through DTC e-commerce and certified training courses.

Ownership category

akta.pro rank

Product category

Electrotherapy Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

Keywords

• Microcurrent stimulation devices
• Pain management therapy
• Electrotherapy medical devices
• Neuromuscular point stimulation
• Clinical pain relief

Headquarters

HQ city

Not specified

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Device Sales: Sale of Dolphin Neurostim devices including Professional and Patient (OTC) versions. Devices are sold as kits with accessories.
2. Professional Education and Training: Online courses, webinars, and live hands-on courses for healthcare professionals seeking certification in MPS Therapy. Includes CEU-accredited programs.
3. Affiliate Program: Third-party affiliates earn commissions for promoting Dolphin Neurostim products through the affiliate program.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Acumed Medical Ltd. designs, manufactures, and sells the Dolphin Neurostim, a handheld DC microcurrent point stimulation device offered in two variants: a Professional version for healthcare practitioners and a Patient/OTC version for home users. The company also delivers structured training programs (online courses, live hands-on workshops, and webinars) that teach MPS Therapy protocols for pain, scar, vagus nerve, and concussion applications, and runs an affiliated research arm, the Center for Pain and Stress Research.

Product overview

ACUMED MEDICAL LTD. offers a portfolio built around the Dolphin Neurostim device—a hardware-based microcurrent point stimulation (MPS) therapy system. The core product line includes the Dolphin Neurostim Professional (for licensed healthcare practitioners) and Dolphin Neurostim Patient/Dolphin OTC (for home use). The company complements its devices with a structured education platform comprising online courses, live hands-on training, and webinars that certify practitioners in various MPS therapy protocols including pain management, scar release, auricular therapy, concussion/brain recovery, and vagus nerve stimulation. The product ecosystem is unified around the proprietary DC micro-impulse technology delivered through the Dolphin device hardware, with education services designed to drive adoption and proper usage of the device across clinical and home settings.

Differentiator

Problem solved

Functional benefit

Products and services

• Dolphin Neurostim Professional A clinical-grade handheld DC microcurrent point stimulation device for licensed healthcare practitioners (chiropractors, physical therapists, pain specialists) used in hospitals and pain clinics for pain management, scar release, vagus nerve therapy, and concussion/brain therapy under the MPS Therapy protocol.
• Dolphin Neurostim Patient/OTC An over-the-counter, consumer-grade handheld DC microcurrent point stimulation device for individual home users seeking non-invasive, drug-free pain relief and adjunctive therapy using the same MPS Therapy protocols as the clinical version.
• MPS Therapy Training Programs Structured training and certification programs, including online courses, live hands-on workshops, and webinars, that teach practitioners how to apply MPS Therapy protocols with the Dolphin Neurostim device.

Quantifiable outcome

• 68% reduction in cortisol levels
• +4 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Electromedical Products International (Alpha-Stim): Manufactures the Alpha-Stim, an FDA-cleared microcurrent electrical therapy device for pain, anxiety, insomnia, and depression. Most directly comparable to Dolphin Neurostim in modality (microcurrent), clinical claims (pain + nervous system regulation), and practitioner + consumer distribution.
• NeuroMetrix: Public company developing neurostimulation devices (e.g., Quell) for chronic pain and nerve-related conditions. Comparable in applying electrical stimulation for pain management, though with a more wearable/consumer-tech angle.
• Avazzia: Sells microcurrent electrotherapy devices used by practitioners and consumers for pain management. Comparable hardware architecture, similar clinical positioning around non-pharmaceutical pain relief, and overlapping practitioner customer base.
• Mettler Electronics: Long-standing manufacturer of clinical electrotherapy devices (TENS, EMS, ultrasound) sold to physical therapy, chiropractic, and rehab clinics. Comparable buyer (PT/OT/chiro) and overlapping pain-management modality.
• RS Medical: Provides electrotherapy and pain management solutions targeted at clinics and workers’ comp/pain-management practices. Comparable go-to-market through clinics and overlapping clinical pain indications.
• Current Solutions: Supplies clinical electrotherapy devices (TENS, EMS, combination units) to PT, chiropractic, and rehab practices. Comparable buyer profile and clinical pain management modality.
• BioElectronics: Markets ActiPatch and RecoveryRx microcurrent/PEMF devices for pain and post-surgical recovery. Comparable consumer-direct and OTC channel strategy plus overlapping pain and recovery use cases.

Broad incumbents

• Omron Healthcare: Large incumbent selling TENS units and other electrotherapy devices directly to consumers and through retail. Comparable end-use (TENS-style pain relief) but competes as a broad consumer brand rather than MPS specialist.
• Chattanooga (DJO Global / Enovis): Major incumbent brand for clinical electrotherapy, rehab, and pain management equipment sold through hospitals and PT clinics. Overlaps with Dolphin on buyer (clinics) and modality (electrotherapy), but operates as a broad portfolio player rather than an MPS specialist.

Emerging players

• Soterix Medical: Specializes in non-invasive brain stimulation and neurostimulation devices (tDCS, HD-tDCS, tACS) used in research and clinical neurology. Comparable neurostimulation orientation and overlap in concussion/neurology use cases.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/playlist?list=PLY948pY9YxqxnxmPqzrzV58Bzrwjgu9cU
• LinkedInlinkedin.com/company/acumed-medical-ltd-

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACUMED MEDICAL LTD.